PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?
Visit https://www.peervoice.com/CPA860 to view the entire programme with slides. After completing “Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?”, participants will be able to: Evaluate recent survival data associated with androgen receptor (AR)-targeted therapies in patients with nmCRPC; Discuss why quality of life (QoL) should be prioritised when managing patients with nmCRPC; and Propose treatment plans for patients with nmCRPC that optimally balance efficacy with QoL, with a focus on adverse events.